Patent · US Active

Expression of mammalian proteins in Pseudomonas fluorescens

US10041102B2 · kind B2 · utility

2Cited by
250References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 5, 2016
Grant dateAug 7, 2018
Priority date
Expiry dateAug 5, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/622
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention is a process for improved production of a recombinant mammalian protein by expression in a Pseudomonad, particularly in a Pseudomonas fluorescens organism. The process improves production of mammalian proteins, particularly human or human-derived proteins, over known expression systems such as E. coli in comparable circumstances. Processes for improved production of isolated mammalian, particularly human, proteins are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.